Stock Events

Stock Events

Halozyme Therapeutics (RV7.F) Q3 2024 Earnings

6AugConfirmed

Q4 2023

Q1 2024

Q2 2024

Q3 2024

0.64

0.7

0.77

0.83

Details

Expected EPS

0.676148325

Actual EPS

0.8328866

Surprise EPS

0.16

Surprise Percent

+23.18%

Description

Halozyme Therapeutics (RV7.F) has reported earnings of 0.8328866 per share for Q3 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.